EGR1 and neoplasm: Gly and estrogen might synergistically affect gene expression, potentially damaging adult and fetal cells. Altered levels of EGR1, HIF1, and CXCL12 may initiate apoptosis, increase tumor angiogenesis, inactivate tumor suppressor genes, and disrupt immune surveillance.